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Objectives: To search for plasmid-mediated qnr genes among waterborne environmental Aeromonas
spp. recovered from Switzerland.
Methods: Isolates presenting MICs of nalidixic acid or ciprofloxacin 1 mg/L were screened for qnr
genes by a multiplex PCR approach followed by sequencing. Plasmids were transferred by transform-
ation, and further analysis of the genetic structures surrounding the qnrS2 gene was carried out by
PCR and sequencing.
Results: A qnrS2 gene was identified from a single Aeromonas allosaccharophila isolate (Lugano lake,
Lugano), as part of a mobile insertion cassette located on a broad host range IncU-type plasmid. This
plasmid co-harboured a class 1 integron containing the aac(6 0)-Ib-cr, blaOXA-1, catB3 and arr-3 gene
cassettes.
Conclusions: These findings strengthen further the role of Aeromonas spp. as a reservoir of antimicro-
bial resistance determinants in the environment.
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Introduction
Quinolones are broad-spectrum antimicrobial agents widely used
in both human and veterinary medicine and therefore found as
residues in the environment.1 Resistance to quinolones is mainly
due to chromosomally encoded mechanisms such as mutations in
the target of quinolones, i.e. DNA gyrase and topoisomerase IV,
or impermeability mechanisms due to either porin loss or quino-
lone extrusion by overexpression of efflux pumps.2 Plasmid-
mediated transferable quinolone resistance (PMQR) determinants
have been identified more recently, being of three types: the
Qnr-type pentapeptide proteins (QnrA, QnrB, QnrC and QnrS)
protecting DNA gyrase from binding to quinolones; the
AAC(60)-Ib-cr aminoglycoside acetyltransferase possessing two
specific amino acid substitutions enabling acetylation of ciproflox-
acin and norfloxacin; and the QepA protein, an efflux pump able
to extrude norfloxacin, ciprofloxacin and enrofloxacin.3–6
Although Qnr determinants have been identified quite exclu-
sively in Enterobacteriaceae, a plasmid-borne qnrS2 gene was
identified recently from environmental Aeromonas strains from
the Seine river in Paris, France.7 The aim of this study was to
further evaluate the spread of qnr genes (qnrC sequence is not
available) among Aeromonas spp. strains with a decreased sus-
ceptibility to nalidixic acid or ciprofloxacin, recovered from
rivers and lakes in the Swiss Alps.
Methods
Water samples were collected between 2002 and 2005 from the
rivers Ticino and Vedeggio and from the lakes Cadagno and
Lugano, located in the southern part of Switzerland. Water samples
were plated out, and growing bacteria were identified by
conventional biochemical methods (API-20NE system, bioMe´rieux,
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Marcy-l’E´toile, France). Susceptibility testing of isolates was
performed using Etest strips containing nalidixic acid or ciprofloxacin.
Isolates exhibiting nalidixic acid or ciprofloxacin MICs 1 mg/L
were selected for further studies. Fifty isolates of Aeromonas spp.
were screened for the presence of qnrA, qnrB and qnrS genes by
multiplex PCR, as described previously.8
Results and discussion
A single isolate, A34, was positive for the qnrS gene, whereas
qnrA and qnrB were not identified. Isolate A34 was from a
water sample originating from the Lugano lake, 2005.
Sequencing identified the qnrS2 gene, identical to that reported
for Aeromonas punctata and Aeromonas media isolates from the
Seine river in France and in a non-Typhi Salmonella clinical
isolate from the USA.7,9 Genotypic identification of isolate A34,
according to the results of sequencing of the gyrB gene,10 ident-
ified Aeromonas allosaccharophila, which is a fish pathogen.
Isolate A34 had reduced susceptibility to all quinolones and
fluoroquinolones tested, and was resistant to amoxicillin and
ticarcillin at high level, to sulphonamides, kanamycin and
tobramycin (Table 1). Sequencing of the quinolone resistance
determining regions (QRDRs) of the gyrA and parC genes of
strain A34 indicated that the GyrA and ParC amino acid
sequences were identical to those from the reference
strain Aeromonas sobria CIP7433, except for a Val-168!Ile
substitution in GyrA, located outside the QRDR, and therefore
considered as wild-type.11
The plasmid harbouring the QnrS2 determinant was extracted
by the Kieser technique and transferred into the Escherichia coli
TOP10 recipient strain by electroporation, as described pre-
viously.7 The E. coli transformant had reduced susceptibility to
quinolones, tobramycin and kanamycin, whereas it was fully
resistant to rifampicin, sulphonamides, amoxicillin and ticarcil-
lin (Table 1). Further analysis of this E. coli transformant ident-
ified a single ca. 80 kb plasmid, p34, hybridizing with an
internal probe for a qnrS-like gene (data not shown). It was
determined to be of the IncU incompatibility group by using
specific primers, as described previously.7 Interestingly, the
qnrS2 genes identified from Aeromonas spp. strains from the
Seine river in France were also found on the same broad host
range IncU-type plasmid.7 PCR assay using primers designed to
anneal to the 50- and 30-conserved sequences of class 1 integrons
resulted in a single amplicon of ca. 3.3 kb. Sequencing identified
four gene cassettes, namely aac(60)-Ib-cr, blaOXA-1, catB3 and
arr-3, encoding an aminoglycoside acetyltransferase, an oxacilli-
nase conferring resistance to penicillins and reduced susceptibility
to cefepime and cefpirome, an acetyltransferase conferring
resistance to chloramphenicol and an ADP-ribosylating transferase
conferring resistance to rifampicin, respectively. Interestingly, the
aac(60)-Ib-cr gene encoding another PMQR determinant was
found in association with the qnrS2 gene on the same plasmid.
Resistance determinant AAC(60)-Ib-cr affects kanamycin, tobra-
mycin, netilmicin and amikacin, in this decreasing order.4
However, once expressed from the natural plasmid p34 in an
E. coli background, the AAC(60)-Ib-cr-mediated resistance to
aminoglycosides was of a low level (if any) (Table 1), suggesting
that additional resistance mechanisms to aminoglycosides were
present in A. allosaccharophila A34. Surprisingly, E. coli TOP10
(p34) and the A34 isolate were of wild-type susceptibility to
chloramphenicol (Table 1), suggesting that the catB3 gene was
probably not expressed in both the donor and the transformant
strains.
The class 1 integron content identified on the qnrS2-carrying
plasmid revealed its perfect identity with other integrons such as
In37, previously described from different qnrA1-positive entero-
bacterial isolates from Shanghai, and also from qnrB10-positive
Enterobacter cloacae and Klebsiella pneumoniae isolates from
Argentina, or qnrB4-positive K. pneumoniae from France.12
However, these In37-like integrons were associated with an
ISCR1 element located at their 30-end, which was not present on
plasmid p34.
PCR mapping and sequencing of the qnrS2 gene environment
showed that it was part of a mobile insertion cassette, the inser-
tion of which had disrupted an mpR gene encoding a putative
zinc-metalloprotease (MpR), in association with a structure
identical to that found on the qnrS2-positive IncU-type plasmids
from A. media and A. punctata (Figure 1).7,13,14 Mobile insertion
cassette elements are peculiar DNA elements made of two inverted
repeats bracketing a DNA sequence without coding sequence for
any transposase.13 Recently, a plasmid-mediated QnrS2 was
identified from another Aeromonas sp. strain, Aeromonas veronii
from Spain.15 However, lack of plasmid characterization and of
sequence determination of the surrounding sequence of the qnrS2
gene in A. veronii prevents further comparison.
Our study identified two PMQR determinants, qnrS2 and
aac(60)-Ib-cr, along with four different antimicrobial resistance
markers, on a single plasmid from A. allosaccharophila recovered
from an aquatic environment in Switzerland. The presence of
those quinolone resistance determinants from a strain with
reduced susceptibility, but still susceptible to quinolones,
Table 1. MICs (mg/L) of antimicrobial agents for
A. allosaccharophila 34, E. coli TOP10 harbouring natural
plasmid p34 and E. coli reference strain TOP10
Antibiotic A. allosaccharophila 34
E. coli
TOP10 with
plasmid p34
E. coli
TOP10
Nalidixic acid 1.5 4 1
Norfloxacin 0.5 1 0.03
Ofloxacin 0.38 0.5 0.01
Ciprofloxacin 0.12 0.25 ,0.01
Moxifloxacin 0.38 0.19 ,0.01
Pefloxacin 0.25 0.75 0.02
Enrofloxacin 0.38 0.38 ,0.01
Rifampicin 16 .256 16
Sulphonamides .256 .256 16
Amikacin 64 2 2
Kanamycin 64 2 1
Tobramycin 32 2 0.38
Gentamicin 0.25 0.12 0.19
Chloramphenicol 4 2 2
Amoxicillin .32 32 6
Ticarcillin .256 .256 4
Ceftazidime ,0.06 ,0.06 ,0.06
Cefotaxime ,0.06 ,0.06 ,0.06
Cefepime ,0.06 0.12 ,0.06
Imipenem ,0.06 ,0.06 ,0.06
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949
suggests that these genes may spread silently. In addition, the fact
that the same mobile insertion cassette-associated qnrS2 structure
has been found in different Aeromonas species from aquatic
environments from distantly related geographical areas may
indicate that these PMQR determinants are widespread, at least in
Europe. Our findings strengthen the possible role of Aeromonas
spp. and of mobile insertion cassette-type structures as vehicles
for the dissemination of quinolone resistance markers. They
may be the link between the progenitor of QnrS proteins
(Vibrionaceae) and enterobacterial clinical species such as
Salmonella.
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Figure 1. Genetic environment of the qnrS2 gene in plasmid p34 from A. allosacharophila 34 and comparison with related plasmid structures. Plasmid
pFBAOT6 is from A. punctata from the UK, whereas plasmid pAS37 is from A. media and A. punctata from France.7,14 Open reading frames are indicated by
horizontal arrows. The right and left inverted repeats (IRR and IRL) are indicated, and duplication sites (CCTCC) are represented by black triangles. The
identified mobile insertion cassette element is bracketed by 22 bp IRL and IRR (black nucleotides are complementary, whereas white nucleotides are not).
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